Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.

@article{VaisiRaygani2007DeterminationOB,
  title={Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.},
  author={Asad Vaisi-Raygani and Zohreh Rahimi and Hadi Kharazi and Heidar Tavilani and Mahdi Aminiani and Amir Hossein Kiani and Aliakbar Vaisi-Raygani and Tayebeh Pourmotabbed},
  journal={Clinical biochemistry},
  year={2007},
  volume={40 9-10},
  pages={629-33}
}
OBJECTIVE The best known clinical application of serum BChE assay is to predict abnormally prolonged apnea following the application of the muscle relaxant succinylcholine. The aim of the present study was to assess the frequency of BChE phenotypes and to predict the risk of apnea for those receiving succinylcholine among the residents in western Iran… CONTINUE READING